6 January 2020 - Australians living with advanced breast cancer now have access to an important new treatment option, with the Australian Government listing a life-changing new medicine on the Pharmaceutical Benefits Scheme.
Australians living with advanced breast cancer now have access to an important new treatment option, with the Morrison Government listing a life-changing new medicine on the Pharmaceutical Benefits Scheme (PBS).
On 1 January 2020, Verzenio (abemaciclib) was listed on the PBS for the first time. It treats non-premenopausal patients with advanced hormone receptor positive human epidermal growth factor receptor 2 negative breast cancer.